Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BLRX
#4858
BioLineRX Ltd
2.380
0
USD
+2.59%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.59%
Monthly Change
-7.03%
6 month change
-15.30%
Year Change
-15.30%
Previous Close
2.320
0
Open
2.380
0
Bid
Ask
Low
2.380
0
High
2.380
0
Volume
1
Markets
US Stock Market
Healthcare
BLRX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
14.55 K
29.8 K
38.46 K
45.27 K
3.72 M
4.35 M
—
Valuation ratios
Enterprise value
-15.36 M
-10.56 M
-9.59 M
-1.48 M
21.42 M
13.95 M
47.68 M
Price to earnings ratio
—
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.63
0.33
0.33
0.95
0.24
0.05
—
Return on equity %
1.36
0.4
0.49
4.58
0.69
0.09
—
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
—
—
100
23.08
67.99
80.51
—
Operating margin %
—
—
4 201.3
1 035.29
70.52
871.78
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
3 595.24
1 262.79
31.86
171.69
—
Liquidity ratios
Quick ratio
—
—
—
1.47
1.56
1.78
—
Current ratio
2.15
5.91
4.87
1.53
1.76
1.95
—
Inventory turnover
—
—
—
1.89
3.63
0.09
—
Asset turnover
—
—
0.01
0.07
0.56
0.03
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
—
BioLineRx Ltd - American Depositary Shares
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
News
BioLineRx Ltd. (BLRX) Q4 2025 Earnings Call Transcript
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
Earnings call transcript: BioLineRx Q3 2025 earnings reveal significant revenue miss
BioLineRx shares rise over 7% on better-than-expected earnings
BioLineRx stock rises after partner receives key patent allowance
Hemispherian receives patent allowance for cancer drug GLIX1
BioLineRx stock rises after securing key patent for cancer treatment
BioLineRx receives key patent for cancer treatment GLIX1
BioLineRx Ltd. (BLRX) Investor Call Transcript
BioLineRx and Hemispherian form joint venture to develop brain cancer drug
BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript
BioLineRx stock maintains buy rating at H.C. Wainwright on cancer data